Skip to content

Clinical and Pathophysiological Description of Ocular Ischemic Syndrome

Pathophysiological Analysis of Ocular Ischemic Syndrome and the Response to Vascular Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00403195
Enrollment
13
Registered
2006-11-23
Start date
2006-11-30
Completion date
2009-01-31
Last updated
2012-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy, Retinal Degeneration

Keywords

Ocular Ischemic Syndrome

Brief summary

The purpose of this study is to characterize the disease Ocular Ischemic Syndrome.

Detailed description

The disease Ocular Ischemic Syndrome (OIS) is not a well described entity. It occurs after a long-standing period of extremely low blood supply to the retina caused by atherosclerosis of the carotid arteries. In this study we will analyze why OIS is developed in some patients and not developed in others. The patients with OIS will be thorough examined and will be compared with 1) a control group of healthy people and 2) with control group of patients with diabetic retinopathy. Furthermore the impact of vascular surgery on OIS will be analyzed.

Interventions

None listed

Sponsors

Rigshospitalet, Denmark
CollaboratorOTHER
University Hospital, Gentofte, Copenhagen
CollaboratorOTHER
Glostrup University Hospital, Copenhagen
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Ocular ischemic syndrome

Exclusion criteria

* Any other active ocular disease

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026